The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Open accessAbstract
We report that in a cohort of 45,965 adults, who were receiving either the ChAdOx1 or the BNT162b2 SARS-CoV-2 vaccines, in those who had no prior infection with SARS-CoV-2, seroconversion rates and quantitative antibody levels after a single dose were lower in older individuals, especially in those aged >60 years. Two vaccine doses achieved high responses across all ages. Antibody levels increased more slowly and to lower levels with a single dose of ChAdOx1 compared with a single dose of BNT162b2, but waned following a single dose of BNT162b2 in older individuals. In descriptive latent class models, we identified four responder subgroups, including a ‘low responder’ group that more commonly consisted of people aged >75 years, males and individuals with long-term health conditions. Given our findings, we propose that available vaccines should be prioritized for those not previously infected and that second doses should be prioritized for individuals aged >60 years. Further data are needed to better understand the extent to which quantitative antibody responses are associated with vaccine-mediated protection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Voysey, M., Clemens, S. A. C., Madhi, S. A., Weckx, L. Y., Folegatti, P. M., Aley, P. K., Angus, B., Baillie, V. L., Barnabas, S. L., Bhorat, Q. E., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32661-1 · Cited by 4,616
Self-citationKhoury, D. S., Cromer, D., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Subbarao, K., Kent, S. J., Triccas, J. A., & Davenport, M. P. (2021) · Nature Medicine · doi:10.1038/s41591-021-01377-8 · Cited by 3,742
Lopez Bernal, J., Andrews, N., Gower, C., Robertson, C., Stowe, J., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O’Doherty, M., et al. (2021) · BMJ · doi:10.1136/bmj.n1088 · Cited by 1,389
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Lumley, S. F., O’Donnell, D., Stoesser, N. E., Matthews, P. C., Howarth, A., Hatch, S. B., Marsden, B. D., Cox, S., James, T., Warren, F., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2034545 · Cited by 940
Self-citationAntibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Krammer, F., Srivastava, K., Alshammary, H., Amoako, A. A., Awawda, M. H., Beach, K. F., Bermúdez-González, M. C., Bielak, D. A., Carreño, J. M., Chernet, R. L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2101667 · Cited by 696
Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Ebinger, J. E., Fert-Bober, J., Printsev, I., Wu, M., Sun, N., Prostko, J. C., Frias, E. C., Stewart, J. L., Van Eyk, J. E., Braun, J. G., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01325-6 · Cited by 538
Saadat, S., Rikhtegaran Tehrani, Z., Logue, J., Newman, M., Frieman, M. B., Harris, A. D., & Sajadi, M. M. (2021) · JAMA · doi:10.1001/jama.2021.3341 · Cited by 364
Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
Ainsworth, M., Andersson, M., Auckland, K., Baillie, J. K., Barnes, E., Beer, S., Beveridge, A., Bibi, S., Blackwell, L., Borak, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30634-4 · Cited by 351
Self-citationImpact of vaccination on new SARS-CoV-2 infections in the United Kingdom
Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Gethings, O., Vihta, K.-D., Jones, J., House, T., VanSteenHouse, H., Bell, I., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01410-w · Cited by 326
Self-citationPrendecki, M., Clarke, C., Brown, J., Cox, A., Gleeson, S., Guckian, M., Randell, P., Pria, A. D., Lightstone, L., Xu, X.-N., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00502-x · Cited by 271
Abu Jabal, K., Ben-Amram, H., Beiruti, K., Batheesh, Y., Sussan, C., Zarka, S., & Edelstein, M. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.6.2100096 · Cited by 271
Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes
Saad-Roy, C. M., Morris, S. E., Metcalf, C. J. E., Mina, M. J., Baker, R. E., Farrar, J., Holmes, E. C., Pybus, O. G., Graham, A. L., Levin, S. A., et al. (2021) · Science · doi:10.1126/science.abg8663 · Cited by 220
Self-citationShrotri, M., Krutikov, M., Palmer, T., Giddings, R., Azmi, B., Subbarao, S., Fuller, C., Irwin-Singer, A., Davies, D., Tut, G., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00289-9 · Cited by 185
Pouwels, K. B., House, T., Pritchard, E., Robotham, J. V., Birrell, P. J., Gelman, A., Vihta, K.-D., Bowers, N., Boreham, I., Thomas, H., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30282-6 · Cited by 176
Self-citationEyre, D. W., Lumley, S. F., Wei, J., Cox, S., James, T., Justice, A., Jesuthasan, G., O'Donnell, D., Howarth, A., Hatch, S. B., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.05.041 · Cited by 131
Self-citationGrzelak, L., Velay, A., Madec, Y., Gallais, F., Staropoli, I., Schmidt‐Mutter, C., Wendling, M.-J., Meyer, N., Planchais, C., Rey, D., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab127 · Cited by 91
Harvala, H., Robb, M. L., Watkins, N. A., Ijaz, S., Dicks, S., Patel, M., Supasa, P., Dejnirattisai, W., Liu, C., Mongkolsapaya, J., et al. (2020) · Transfusion Medicine · doi:10.1111/tme.12746 · Cited by 89
Self-citationGoldberg, Y., Mandel, M., Woodbridge, Y., Fluss, R., Novikov, I., Yaari, R., Ziv, A., Freedman, L. S., & Huppert, A. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac060 · Cited by 65
Ward, H., Cooke, G., Whitaker, M. D., Redd, R., Eales, O. D., Brown, J. C., Collet, K., Cooper, E., Daunt, A., Jones, K., et al. (2021) · medRxiv · doi:10.1101/2021.02.26.21252512 · Cited by 53
A review of vaccine effects on women in light of the COVID-19 pandemic
Chang, W. (2020) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2020.09.006 · Cited by 49
Angyal, A., Longet, S., Moore, S. C., Payne, R. P., Harding, A. C., Tipton, T., Rongkard, P., Ali, M., Hering, L. M., Meardon, N., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3812375 · Cited by 42
Self-citationSubbarao, S., Warrener, L., Höschler, K., Perry, K. R., Shute, J., Whitaker, H., O’Brien, M., Baawuah, F., Moss, P. A. H., Parry, H., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.12.2100329 · Cited by 41
Parry, H., Tut, G., Bruton, R. K., Faustini, S. E., Stephens, C., Saunders, P., Bentley, C., Hilyard, K., Brown, K. E., Amirthalingam, G., et al. (2021) · eLife · doi:10.7554/elife.69375 · Cited by 37
Ebinger, J. E., Fert‐Bober, J., Printsev, I., Wu, M. J., Sun, N., Figueiredo, J. C., Eyk, J. E. V., Braun, J. G., Cheng, S. C., & Sobhani, K. (2021) · medRxiv · doi:10.1101/2021.02.23.21252230 · Cited by 30
Eyre, D. W., Lumley, S., Wei, J., Cox, S., James, T. J., Justice, A., Jesuthasan, G., O’Donnell, D., Howarth, A., Hatch, S. B., et al. (2021) · medRxiv · doi:10.1101/2021.03.21.21254061 · Cited by 28
Self-citationParry, H., Tut, G., Faustini, S. E., Stephens, C., Saunders, P., Bentley, C., Hilyard, K., Brown, K. E., Amirthalingam, G., Charlton, S., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3816840 · Cited by 17
SARS-CoV-2 seropositivity after infection and antibody response to mRNA-based vaccinationPreprint
Ciccone, E. J., Zhu, D., Ajeen, R., Lodge, E. K., Shook‐Sa, B. E., Boyce, R. M., Aiello, A. E., & COVID HCP Study Team (2021) · medRxiv · doi:10.1101/2021.02.09.21251319 · Cited by 14
Parry, H., Tut, G., Zuo, J., & Moss, P. A. H. (2021) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4740080 · Cited by 12
Cited by
Tregoning, J. S., Flight, K. E., Higham, S. L., Wang, Z., & Pierce, B. F. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00592-1 · Cited by 1,125
Pouwels, K. B., Pritchard, E., Matthews, P. C., Stoesser, N., Eyre, D. W., Vihta, K.-D., House, T., Hay, J., Bell, J. I., Newton, J. N., et al. (2021) · doi:10.1101/2021.08.18.21262237 · Cited by 543
Self-citationEffect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
Eyre, D. W., Taylor, D., Purver, M., Chapman, D., Fowler, T., Pouwels, K. B., Walker, A. S., & Peto, T. E. A. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2116597 · Cited by 464
“However, reductions in antibody levels 23 and vaccine effectiveness 8 over time provide support for the importance of biologic explanations.”
Self-citationSerological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
(2021) · doi:10.1038/s41467-021-27410-5 · Cited by 117
Contribution of low population immunity to the severe Omicron BA.2 outbreak in Hong Kong
Chen, L.-L., Abdullah, S. M. U., Chan, W.-M., Chan, B. P.-C., Ip, J. D., Chu, A. W.-H., Lu, L., Zhang, X., Zhao, Y., Chuang, V. W.-M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31395-0 · Cited by 72
Metadata
- Authors
- Wei, J., Stoesser, N., Matthews, P. C., Ayoubkhani, D., Studley, R., Bell, I., Bell, J. I., Newton, J. N., Farrar, J., Diamond, I., Rourke, E., Howarth, A., Marsden, B. D., Hoosdally, S., Jones, E. Y., Stuart, D. I., Crook, D. W., Peto, T. E. A., Pouwels, K. B., Eyre, D. W., Walker, A. S., the COVID-19 Infection Survey team, Lambert, A., Thomas, T., Black, R., Felton, A., Crees, M., Jones, J., Lloyd, L., Sutherland, E., Pritchard, E., Vihta, K.-D., Doherty, G., Kavanagh, J., Chau, K. K., Hatch, S. B., Ebner, D., Ferreira, L. M., Christott, T., Dejnirattisai, W., Mongkolsapaya, J., Cameron, S., Tamblin-Hopper, P., Wolna, M., Brown, R., Cornall, R., Screaton, G., Lythgoe, K., Bonsall, D., Golubchik, T., Fryer, H., Cox, S., Paddon, K., James, T., House, T., Robotham, J., Birrell, P., Jordan, H., Sheppard, T., Athey, G., Moody, D., Curry, L., Brereton, P., Jarvis, I., Godsmark, A., Morris, G., Mallick, B., Eeles, P., Hay, J., VanSteenhouse, H., & Lee, J.
- Venue
- Nature Microbiology
- Published
- 2021-07-21
- Volume
- 6
- Issue
- 9
- Pages
- 1140-1149
- ISSN
- 2058-5276 (ISSN-L)
- OpenAlex
- W3179750870
- Cited by
- 331
- References
- 30
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.